| |
Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or risk-equivalent - Results of the Phase 3 ORION-11 trial
|
| |
| |
Download the PDF
European Society of Cardiology meeting 2019 Aug 31-Sept 2 Paris
Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or risk-equivalent - Results of the Phase 3 ORION-11 trial
European Society of Cardiology meeting 2019 Aug 31-Sept 2 Paris
|
|
| |
| |
|
|
|
